Medscape

Mobile Tools Aid Weight Loss and Liver Wellness in NAFLD

A meta-analysis finds that mobile health tools, such as apps and text messages, support weight management and improve liver ...

Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...

Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Y…

Global biopharma leader CSL (ASX:CSL; USOTC:CSLLY) today announced five-year (60-month) results from the pivotal Phase 3 HOPE ...
MedPage Today on MSN

Gene Therapy Maintains Efficacy in Hemophilia B Out to 5 Years

Based on initial positive results from HOPE-B, etranacogene dezaparvovec became the first gene therapy approved for adults ...
BMJ Open

Exploring a panel of serum biomarkers for cancer risk in patients with non-specific symptoms: a comparative analysis of feature selection methods

Objectives Delays in cancer diagnosis for patients with non-specific symptoms (NSSs) lead to poorer outcomes. Rapid Diagnostic Clinics (RDCs) expedite care, but most NSS patients do not have cancer, ...

U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Medindia

What Happens When You Swap Grains for Potatoes

Are potatoes and grains interchangeable? Not quite. Each offers unique nutrients, and swapping one for the other can leave surprising gaps.
Hosted on MSN

What Happens to Your Body When You Take Creatine and Beta-Alanine Together?

Creatine and beta-alanine are widely used dietary supplements that support physical fitness and enhance muscle and cognitive performance. They are often taken together to boost performance, strength, ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...
eLife

Global molecular landscape of early MASLD progression in obesity

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
NPR

That's What They Say

Funner, snuck, and LOL are all things that we're hearing people say these days.That's What They Say is a weekly segment on Michigan Public that explores our changing language. University of Michigan ...
BMJ

β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis

Objective To conduct a systematic review and meta-analysis of the evidence on the effects of β-alanine supplementation on exercise capacity and performance. Design This study was designed in ...